现已明确,轻度慢性炎症在急性冠脉综合征(ACS)的发生、发展中扮演了重要的角色。作为炎症敏感标记物之一的超敏C反应蛋白(hs-CRP),其对于ACS的诊断及预测价值已受到广泛重视,被认为是该病的独立危险因子。已知降低其水平有可能对该病的患者具有潜在的治疗价值,而且对于hs-CRP水平偏高的正常人群,有可能预防首次冠脉事件的发生,但这还需要更多的临床证据证明。 It is clear that mild chronic inflammation plays an important role in the occurrence and development of acute coronary syndrome (ACS). Highly sensitive C-reactive protein (hs-CRP), one of the most sensitive markers of inflammation, has received extensive attention for the diagnosis and prognosis of ACS and is considered as an independent risk factor for this disease. It is known that lowering their levels may have potential therapeutic value in patients with this disease, and it is possible to prevent the occurrence of first coronary events in normal people with high hs-CRP levels, but this still needs more clinical evidence to prove .